How to buy Aditxt stock | $2.81

Aditxt, Inc is a biotechnology business based in the US. Aditxt shares (ADTX) are listed on the NASDAQ and all prices are listed in US Dollars. Aditxt employs 43 staff and has a market cap (total outstanding shares value) of 0.00.

Aditxt stock price (NASDAQ: ADTX)

Use our graph to track the performance of ADTX stocks over time.

Aditxt shares at a glance

• Key figures

Information last updated 2021-07-28.

Latest market close	$2.81
52-week range	$1.66 - $9.58
50-day moving average	$2.60
200-day moving average	$2.89
Wall St. target price	$14.00
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.60

Buy Aditxt shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Aditxt stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Aditxt, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Aditxt price performance over time

Historical closes compared with the close of $2.81 from 2021-05-28

1 week (2021-07-22)	N/A
1 month (2021-07-02)	7.66%
3 months (2021-04-30)	-1.75%
6 months (2021-01-29)	N/A

1 year (2020-07-29)	N/A
2 years (2019-07-29)	N/A
3 years (2018-07-29)	N/A
5 years (2016-07-29)	N/A

Aditxt financials

Gross profit TTM	$0
Return on assets TTM	-95.4%
Return on equity TTM	-365.54%
Profit margin	0%
Book value	$0.79
Market capitalisation	$31.9 million

TTM: trailing 12 months

Shorting Aditxt shares

There are currently 510,047 Aditxt shares held short by investors – that's known as Aditxt's "short interest". This figure is 4.4% down from 533,715 last month.

There are a few different ways that this level of interest in shorting Aditxt shares can be evaluated.

Aditxt's "short interest ratio" (SIR)

Aditxt's "short interest ratio" (SIR) is the quantity of Aditxt shares currently shorted divided by the average quantity of Aditxt shares traded daily (recently around 100009.21568627). Aditxt's SIR currently stands at 5.1. In other words for every 100,000 Aditxt shares traded daily on the market, roughly 5100 shares are currently held short.

However Aditxt's short interest can also be evaluated against the total number of Aditxt shares, or, against the total number of tradable Aditxt shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aditxt's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Aditxt shares in existence, roughly 30 shares are currently held short) or 0.0466% of the tradable shares (for every 100,000 tradable Aditxt shares, roughly 47 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Aditxt.

Find out more about how you can short Aditxt stock.

Aditxt share dividends

We're not expecting Aditxt to pay a dividend over the next 12 months.

Aditxt overview

ADiTx Therapeutics, Inc. , a biotech company, develops technologies focuses on improving the health of the immune system through immune reprogramming and monitoring. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. ADiTx Therapeutics has a license agreement with Loma Linda University and Leland Stanford Junior University. ADiTx Therapeutics, Inc. was incorporated in 2017 and is headquartered in Mountain View, California.

Frequently asked questions

What percentage of Aditxt is owned by insiders or institutions?
Currently 15.159% of Aditxt shares are held by insiders and 8.115% by institutions. How many people work for Aditxt?
Latest data suggests 43 work at Aditxt. When does the fiscal year end for Aditxt?
Aditxt's fiscal year ends in December. Where is Aditxt based?
Aditxt's address is: 737 N. Fifth Street, Richmond, VA, United States, 23219 What is Aditxt's ISIN number?
Aditxt's international securities identification number is: US0070251097